naltrexone and carbachol

naltrexone has been researched along with carbachol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chance, WT; Finkelstein, JA; Fischer, JE; van Lammeren, FM1
Duan, N; Kapusta, DR; Minor, LD; Mosaddeghi, M; Paul, D1
Minami, M; Nakagawa, T; Ozawa, T; Satoh, M; Watanabe, T1
Chang, JP; Chang, KJ; Gengo, PJ; Holt, JD; O'Neill, SJ; Pendergast, W; Watson, MJ; Wei, K1

Other Studies

5 other study(ies) available for naltrexone and carbachol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Analysis of the interaction of naltrexone with eating following adrenergic and cholinergic stimulation of the hypothalamus.
    Neuropharmacology, 1982, Volume: 21, Issue:9

    Topics: Animals; Carbachol; Dose-Response Relationship, Drug; Feeding Behavior; Hypothalamus; Male; Naloxone; Naltrexone; Norepinephrine; Rats; Rats, Inbred Strains

1982
Effects of kappa-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney.
    European journal of pharmacology, 1995, May-26, Volume: 289, Issue:3

    Topics: Animals; Carbachol; Ethylketocyclazocine; Hydrolysis; In Vitro Techniques; Kidney Cortex; Male; Naltrexone; Norepinephrine; Phosphatidylinositols; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stimulation, Chemical

1995
[A molecular mechanism for supersensitization of adenylyl cyclase system in cloned opioid receptor-transfected cells following sustained opioid treatment].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112 Suppl 1

    Topics: Adenylyl Cyclases; Analgesics; Animals; Atropine; Benzeneacetamides; Carbachol; CHO Cells; Clone Cells; Cricetinae; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; GTP Phosphohydrolases; Morphine; Muscarinic Agonists; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, delta; Transfection

1998
DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Animals; Benzhydryl Compounds; Blood Gas Analysis; Carbachol; Convulsants; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Naltrexone; Narcotic Antagonists; Pain Measurement; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Urinary Bladder; Urination; Vas Deferens

2005